ARYx Therapeutics

About:

ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.

Website: http://www.aryx.com

Top Investors: New Enterprise Associates, OrbiMed, MPM Capital, Montreux Equity Partners, ATEL Ventures

Description:

ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.